Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9B0P2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.624 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.391 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.594 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.617 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.623 |
CLV_PCSK_PC1ET2_1 | 46 | 48 | PF00082 | 0.594 |
CLV_PCSK_PC1ET2_1 | 70 | 72 | PF00082 | 0.617 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.659 |
DEG_APCC_DBOX_1 | 70 | 78 | PF00400 | 0.428 |
DOC_USP7_MATH_1 | 75 | 79 | PF00917 | 0.454 |
LIG_14-3-3_CanoR_1 | 10 | 16 | PF00244 | 0.588 |
LIG_14-3-3_CanoR_1 | 57 | 66 | PF00244 | 0.468 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.656 |
LIG_BRCT_BRCA1_1 | 22 | 26 | PF00533 | 0.598 |
LIG_EH1_1 | 2 | 10 | PF00400 | 0.688 |
LIG_LIR_Gen_1 | 78 | 87 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 23 | 29 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 38 | 42 | PF02991 | 0.259 |
LIG_SH2_CRK | 29 | 33 | PF00017 | 0.438 |
LIG_SH2_CRK | 45 | 49 | PF00017 | 0.389 |
LIG_SH2_STAP1 | 55 | 59 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.439 |
LIG_SH3_1 | 47 | 53 | PF00018 | 0.407 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.407 |
LIG_UBA3_1 | 5 | 11 | PF00899 | 0.530 |
LIG_WRC_WIRS_1 | 12 | 17 | PF05994 | 0.586 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.562 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.688 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.589 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.335 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.453 |
MOD_SUMO_for_1 | 53 | 56 | PF00179 | 0.502 |
TRG_DiLeu_BaEn_3 | 61 | 67 | PF01217 | 0.475 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.390 |
TRG_ER_diArg_1 | 87 | 89 | PF00400 | 0.418 |
TRG_Pf-PMV_PEXEL_1 | 57 | 61 | PF00026 | 0.674 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IMI3 | Leptomonas seymouri | 80% | 100% |
A0A3Q8IEQ3 | Leishmania donovani | 95% | 100% |
A0A422P532 | Trypanosoma rangeli | 56% | 80% |
A4HI67 | Leishmania braziliensis | 90% | 100% |
A4I5E4 | Leishmania infantum | 95% | 100% |
C9ZQS9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 99% |
Q4Q7J0 | Leishmania major | 91% | 100% |